Post transplant lymphoproliferative disorder overview: Difference between revisions
Created page with "__NOTOC__ {{Post transplant lymphoproliferative disorder}} {{CMG}} Please help WikiDoc by adding more content here. It's easy! Click here to l..." |
No edit summary |
||
| Line 9: | Line 9: | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Needs Content]] | [[Category:Needs Content]] | ||
[[Category:Transplantation medicine]] | [[Category:Transplantation medicine]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Latest revision as of 18:44, 27 August 2015
|
Post transplant lymphoproliferative disorder Microchapters |
|
Differentiating Post transplant lymphoproliferative disorder from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Post transplant lymphoproliferative disorder overview On the Web |
|
American Roentgen Ray Society Images of Post transplant lymphoproliferative disorder overview |
|
FDA on Post transplant lymphoproliferative disorder overview |
|
CDC on Post transplant lymphoproliferative disorder overview |
|
Post transplant lymphoproliferative disorder overview in the news |
|
Blogs on Post transplant lymphoproliferative disorder overview |
|
Directions to Hospitals Treating Post transplant lymphoproliferative disorder |
|
Risk calculators and risk factors for Post transplant lymphoproliferative disorder overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Post-transplant lymphoproliferative disorder (PTLD) is the name given to a group of B cell lymphomas occurring in immunosuppressed patients following organ transplant.